Published in the Journal of Veterinary Internal Medicine, this retrospective study evaluated 24 dogs diagnosed with histologically confirmed mast cell tumors (MCT) of the muzzle—a location noted for unusually aggressive behavior compared to other anatomical sites.
Researchers reviewed data on signalment, tumor grade, stage, treatment approaches, and clinical outcomes. Of the 24 dogs, 23 received treatment involving surgery, radiotherapy, chemotherapy, or combinations thereof. Tumors were categorized as Grade I (n=2), Grade II (n=15), and Grade III (n=7). Staging ranged from stage 0 to stage 4, with wide variation in disease extent at diagnosis.
Survival outcomes reflected a strong influence of tumor aggressiveness. Among treated dogs, mean and median survival times were 36 and 30 months. The most important prognostic markers were tumor grade and presence of metastasis at the time of diagnosis. Dogs with Grade I or II MCT survived significantly longer than those with Grade III tumors.
Other variables—including age, sex, disease burden (gross vs. microscopic), and treatment modality—did not significantly affect survival time. Local disease control was achieved in 75% of dogs at 1 year and 50% at 3 years, with tumor grade again serving as the primary predictor of recurrence risk. Disease-free intervals decreased progressively from Grade I to Grade III tumors.
Importantly, 8 of 9 dogs that died from MCT exhibited local or regional progression, underscoring the aggressive nature of muzzle tumors. The authors emphasize that MCTs in this location demonstrate higher regional metastatic rates than those reported at other anatomical sites.
These findings highlight the need for vigilant staging, aggressive local therapy, and close follow-up when treating muzzle MCT, particularly in higher-grade tumors.
Source: Gieger, T., Théon, A., Werner, J., McEntee, M., Rassnick, K., & Decock, H. (2003). Biologic Behavior and Prognostic Factors for Mast Cell Tumors of the Canine Muzzle: 24 Cases (1990–2001). Journal of Veterinary Internal Medicine. Published September 1, 2003.
